statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	596
CN - Cina	266
SG - Singapore	262
BR - Brasile	77
HK - Hong Kong	73
GB - Regno Unito	50
KR - Corea	48
IT - Italia	45
VN - Vietnam	39
BD - Bangladesh	37
FI - Finlandia	35
RU - Federazione Russa	26
SE - Svezia	26
DE - Germania	23
LT - Lituania	13
FR - Francia	11
CA - Canada	10
AR - Argentina	7
IN - India	7
IQ - Iraq	6
NL - Olanda	6
ZA - Sudafrica	5
IE - Irlanda	4
PE - Perù	4
IL - Israele	3
JP - Giappone	3
PK - Pakistan	3
UA - Ucraina	3
AL - Albania	2
EC - Ecuador	2
LA - Repubblica Popolare Democratica del Laos	2
MX - Messico	2
NI - Nicaragua	2
OM - Oman	2
PA - Panama	2
PL - Polonia	2
PT - Portogallo	2
QA - Qatar	2
TR - Turchia	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BG - Bulgaria	1
BO - Bolivia	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
HN - Honduras	1
HU - Ungheria	1
IS - Islanda	1
KG - Kirghizistan	1
LK - Sri Lanka	1
LV - Lettonia	1
MA - Marocco	1
NP - Nepal	1
PH - Filippine	1
PS - Palestinian Territory	1
PY - Paraguay	1
RO - Romania	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
TW - Taiwan	1
VE - Venezuela	1
Totale	1.739

Nome	#
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients	187
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes	163
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia	161
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells	146
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells	143
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients	142
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS	140
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression	140
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation	136
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside	130
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines	128
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia	124
Totale	1.740

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	89	0	0	0	4	9	20	1	14	16	3	8	14
2023/2024	113	3	5	6	21	17	11	21	2	5	0	15	7
2024/2025	586	10	3	0	37	109	87	15	30	91	15	98	91
2025/2026	952	85	87	122	106	110	41	91	21	57	90	43	99
Totale													1.740